FDA grants ‘emergency use authorization’ to antiviral drug remdesivir for COVID-19 treatment
The Food and Drug Administration (FDA) granted “emergency use authorization” to the drug remdesivir after a clinical trial showed it reduced the recovery time for seriously ill coronavirus (COVID-19) patients by 31 percent.